Intra-Arterial and Intracavitary Cancer Chemotherapy: Proceedings of the Conference on Intra-arterial and Intracavitary Chemotheraphy, San Diego, California, February 24–25, 1984

Front Matter....Pages I-XI
Pharmacokinetic Rationale for Intraarterial Therapy....Pages 1-10
Technical Aspects of Arterial Access and Constant Infusion....Pages 11-31
Management, Complications, and Evaluation of Intra-arterial Infusions....Pages 33-40
Pharmacokinetic Rationale for Intracavitary Therapy....Pages 41-51
Surgical Principles of Intraperitoneal Access and Therapy....Pages 53-60
Medical Principles of Intraperitoneal and Intrapleural Chemotherapy....Pages 61-69
Intra-arterial Therapy of Hepatic Metastases....Pages 71-76
Intra-arterial vs Intravenous FUDR for Colorectal Cancer Metastatic to the Liver: A Northern California Oncology Group Study....Pages 77-84
Randomized Study of Intrahepatic vs Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal Carcinoma (Preliminary Results)....Pages 85-95
The Rationale and Methodology for Intra-arterial Chemotherapy with BCNU as Treatment for Glioblastoma....Pages 97-109
Intra-arterial Cis-Platinum in Advanced Solid Tumors....Pages 111-124
Hepatic Arterial Infusion of Floxuridine, Adriamycin, and Mitomycin C for Primary Liver Neoplasms....Pages 125-140
Intraarterial Adriamycin, Radiation Therapy, and Surgical Excision for Extremity Skeletal and Soft-Tissue Sarcomas....Pages 141-152
Phase I Trials and Pharmacokinetic Studies of Intraperitoneal Cisplatin, Melphalan, Methotrexate, and Cytarabine....Pages 153-166
A Phase I Trial of Intracavitary Doxorubicin (Adriamycin) Alternating with Cisplatin....Pages 167-177
Clinical Pharmacology of Intraperitoneal (IP) Bolus Mitomycin C and Continuous IP Infusion 5-Fluorouracil....Pages 179-186
Intraperitoneal Adriamycin and 5-Fluorouracil in Ovarian Cancer....Pages 187-197
Combination Cisplatin-Based Intracavitary Chemotherapy....Pages 199-209
Intravesical Doxorubicin for Prophylaxis in the Management of Recurrent Superficial Bladder Carcinoma — An Update....Pages 211-217
Degradable Starch Microspheres....Pages 219-226
Magnetic Drug-Containing Microspheres....Pages 227-245
Polymer Immobilized Doxorubicin as A Regional Therapeutic Agent....Pages 247-255
The Use of Radiolabeled Antibody in Cancer Chemotherapy....Pages 257-270
Intracavitary Hyperthermia and Intra-arterial Chemotherapy....Pages 271-281
Combination Hyperthermia and Intra-arterial Chemotherapy....Pages 283-286